Review



vegfc  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems vegfc
    Vegfc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 34 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vegfc/product/R&D Systems
    Average 94 stars, based on 34 article reviews
    vegfc - by Bioz Stars, 2026-06
    94/100 stars

    Images



    Similar Products

    94
    Bio-Techne corporation recombinant human vegf-c (cys156ser) protein
    Recombinant Human Vegf C (Cys156ser) Protein, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human vegf-c (cys156ser) protein/product/Bio-Techne corporation
    Average 94 stars, based on 1 article reviews
    recombinant human vegf-c (cys156ser) protein - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    R&D Systems vegfc
    Vegfc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vegfc/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    vegfc - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant human vegfc
    Recombinant Human Vegfc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human vegfc/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    recombinant human vegfc - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    R&D Systems vegfc 156s 752 vc
    Vegfc 156s 752 Vc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vegfc 156s 752 vc/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    vegfc 156s 752 vc - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant human vegfc 156s
    Recombinant Human Vegfc 156s, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human vegfc 156s/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    recombinant human vegfc 156s - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    90
    Genechem recombinant adeno-associated virus encoding a full-length human vegfc cdna
    <t>AAV-VEGFC</t> increases local lymphatic drainage and reduces alveolar bone loss in RA-associated periodontitis. Four-month-old TNF-Tg mice received local injection of AAV-GFP control virus (left maxillary) or AAV-VEGFC virus (right maxillary) into periodontal tissues of the left and right maxillary first molar, respectively. Two months after viral injection, mice were sacrificed and analyzed. (A) Expression of virus-encoded human VEGFC in periodontal tissues of TNF-Tg mice. (B) Paraffin sections of maxillae were subjected to IF for PDPN (red) and αSMA (green). Representative images of periodontal tissue showing the distribution of PDPN+/αSMA− lymphatic capillaries (red), PDPN+/αSMA+ collecting LVs (yellow), and PDPN−/αSMA+ blood vessels (green). Quantification of the PDPN+αSMA− area or PDPN+αSMA+ area to tissue area (%) was determined. The number of PDPN+αSMA+ collecting LVs per mm2 tissue areas (#/mm2) was calculated. (C) An example of in vivo washout of ICG in periodontal tissues reflecting lymph flow through all time points. ICG clearance (%) was quantified. Values shown are mean ± SEM. *p < 0.05 versus AAV-GFP control virus at the same time point. (D) Representative 3D scanned sections (upper panels) and reconstructed sections (lower panels) along the longitudinal direction of the maxillae. Bone mineral density (BMD, g/cm2) was analyzed. (E) Representative images of H&E-stained paraffin sections. Measurement of the bone levels by comparing the distance from the cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) in μm was determined. (F) Representative images of TRAP-stained paraffin sections. The percentage of alveolar bone surface covered by osteoclasts (Oc.S/B.S) was determined. (G) Representative images of ALP-stained paraffin sections. The percentage of alveolar bone surface covered by osteoblasts (Ob.S/B.S) was determined. *p < 0.05 versus AAV-GFP control virus. N = 6–8. A two-tailed unpaired Student’s t-test was performed.
    Recombinant Adeno Associated Virus Encoding A Full Length Human Vegfc Cdna, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant adeno-associated virus encoding a full-length human vegfc cdna/product/Genechem
    Average 90 stars, based on 1 article reviews
    recombinant adeno-associated virus encoding a full-length human vegfc cdna - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    AAV-VEGFC increases local lymphatic drainage and reduces alveolar bone loss in RA-associated periodontitis. Four-month-old TNF-Tg mice received local injection of AAV-GFP control virus (left maxillary) or AAV-VEGFC virus (right maxillary) into periodontal tissues of the left and right maxillary first molar, respectively. Two months after viral injection, mice were sacrificed and analyzed. (A) Expression of virus-encoded human VEGFC in periodontal tissues of TNF-Tg mice. (B) Paraffin sections of maxillae were subjected to IF for PDPN (red) and αSMA (green). Representative images of periodontal tissue showing the distribution of PDPN+/αSMA− lymphatic capillaries (red), PDPN+/αSMA+ collecting LVs (yellow), and PDPN−/αSMA+ blood vessels (green). Quantification of the PDPN+αSMA− area or PDPN+αSMA+ area to tissue area (%) was determined. The number of PDPN+αSMA+ collecting LVs per mm2 tissue areas (#/mm2) was calculated. (C) An example of in vivo washout of ICG in periodontal tissues reflecting lymph flow through all time points. ICG clearance (%) was quantified. Values shown are mean ± SEM. *p < 0.05 versus AAV-GFP control virus at the same time point. (D) Representative 3D scanned sections (upper panels) and reconstructed sections (lower panels) along the longitudinal direction of the maxillae. Bone mineral density (BMD, g/cm2) was analyzed. (E) Representative images of H&E-stained paraffin sections. Measurement of the bone levels by comparing the distance from the cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) in μm was determined. (F) Representative images of TRAP-stained paraffin sections. The percentage of alveolar bone surface covered by osteoclasts (Oc.S/B.S) was determined. (G) Representative images of ALP-stained paraffin sections. The percentage of alveolar bone surface covered by osteoblasts (Ob.S/B.S) was determined. *p < 0.05 versus AAV-GFP control virus. N = 6–8. A two-tailed unpaired Student’s t-test was performed.

    Journal: The Journal of pathology

    Article Title: Effect of VEGFC on lymph flow and inflammation-induced alveolar bone loss

    doi: 10.1002/path.5456

    Figure Lengend Snippet: AAV-VEGFC increases local lymphatic drainage and reduces alveolar bone loss in RA-associated periodontitis. Four-month-old TNF-Tg mice received local injection of AAV-GFP control virus (left maxillary) or AAV-VEGFC virus (right maxillary) into periodontal tissues of the left and right maxillary first molar, respectively. Two months after viral injection, mice were sacrificed and analyzed. (A) Expression of virus-encoded human VEGFC in periodontal tissues of TNF-Tg mice. (B) Paraffin sections of maxillae were subjected to IF for PDPN (red) and αSMA (green). Representative images of periodontal tissue showing the distribution of PDPN+/αSMA− lymphatic capillaries (red), PDPN+/αSMA+ collecting LVs (yellow), and PDPN−/αSMA+ blood vessels (green). Quantification of the PDPN+αSMA− area or PDPN+αSMA+ area to tissue area (%) was determined. The number of PDPN+αSMA+ collecting LVs per mm2 tissue areas (#/mm2) was calculated. (C) An example of in vivo washout of ICG in periodontal tissues reflecting lymph flow through all time points. ICG clearance (%) was quantified. Values shown are mean ± SEM. *p < 0.05 versus AAV-GFP control virus at the same time point. (D) Representative 3D scanned sections (upper panels) and reconstructed sections (lower panels) along the longitudinal direction of the maxillae. Bone mineral density (BMD, g/cm2) was analyzed. (E) Representative images of H&E-stained paraffin sections. Measurement of the bone levels by comparing the distance from the cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) in μm was determined. (F) Representative images of TRAP-stained paraffin sections. The percentage of alveolar bone surface covered by osteoclasts (Oc.S/B.S) was determined. (G) Representative images of ALP-stained paraffin sections. The percentage of alveolar bone surface covered by osteoblasts (Ob.S/B.S) was determined. *p < 0.05 versus AAV-GFP control virus. N = 6–8. A two-tailed unpaired Student’s t-test was performed.

    Article Snippet: A recombinant adeno-associated virus (AAV) encoding a full-length human VEGFC cDNA (NM_005429) was purchased from Genechem Biotech Inc (Shanghai, PR China).

    Techniques: Injection, Virus, Expressing, In Vivo, Staining, Two Tailed Test

    AAV-VEGFC increases local lymphatic drainage and reduces alveolar bone loss in ligature-induced periodontitis. Two-month-old WT mice were randomly divided into two groups (six mice per group). One group received local injection of AAV-GFP control virus in periodontal tissues of both the left and right maxillary first molar. Another group received AAV-VEGFC virus injection. Two weeks later, a 5–0 silk ligature was tied around the right maxillary first molar and the contralateral tooth was left unligated to serve as the baseline control. All the mice were sacrificed and analyzed 2 weeks after placement of the ligature. (A) Paraffin sections of maxillae were subjected to IF for PDPN (red) and αSMA (green). Representative images of periodontal tissue showing the distribution of PDPN+/αSMA− lymphatic capillaries (red), PDPN+/αSMA+ collecting LVs (yellow), and PDPN−/αSMA+ blood vessels (green). Quantification of the PDPN+αSMA− area or PDPN+αSMA+ area to tissue area (%) was determined. The number of PDPN+αSMA+ collecting LVs per mm2 tissue areas (#/mm2) was calculated. (B) An example of in vivo washout of ICG in periodontal tissues reflecting lymph flow through all time points. ICG clearance (%) was quantified. Values shown are mean ± SEM. *p < 0.05 versus control + AAV-GFP, #p < 0.05 versus periodontitis + AAV-VEGFC, at the same time point. (C) Representative 3D scanned sections (upper panels) and reconstructed sections (lower panels) along the longitudinal direction of the maxillae. Bone mineral density (BMD, g/cm2) was analyzed. (D) Representative images of H&E-stained paraffin sections. Measurement of the bone levels by comparing the distance from the cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) in μm was determined. (E) Representative images of TRAP-stained paraffin sections. The percentage of alveolar bone surface covered by osteoclasts (Oc.S/B.S) was determined. (F) Representative images of ALP-stained paraffin sections. The percentage of alveolar bone surface covered by osteoblasts (Ob.S/B.S) was determined. *p < 0.05 in the indicated groups. N = 6. One-way ANOVA followed by Dunnett’s post hoc multiple comparisons test was performed.

    Journal: The Journal of pathology

    Article Title: Effect of VEGFC on lymph flow and inflammation-induced alveolar bone loss

    doi: 10.1002/path.5456

    Figure Lengend Snippet: AAV-VEGFC increases local lymphatic drainage and reduces alveolar bone loss in ligature-induced periodontitis. Two-month-old WT mice were randomly divided into two groups (six mice per group). One group received local injection of AAV-GFP control virus in periodontal tissues of both the left and right maxillary first molar. Another group received AAV-VEGFC virus injection. Two weeks later, a 5–0 silk ligature was tied around the right maxillary first molar and the contralateral tooth was left unligated to serve as the baseline control. All the mice were sacrificed and analyzed 2 weeks after placement of the ligature. (A) Paraffin sections of maxillae were subjected to IF for PDPN (red) and αSMA (green). Representative images of periodontal tissue showing the distribution of PDPN+/αSMA− lymphatic capillaries (red), PDPN+/αSMA+ collecting LVs (yellow), and PDPN−/αSMA+ blood vessels (green). Quantification of the PDPN+αSMA− area or PDPN+αSMA+ area to tissue area (%) was determined. The number of PDPN+αSMA+ collecting LVs per mm2 tissue areas (#/mm2) was calculated. (B) An example of in vivo washout of ICG in periodontal tissues reflecting lymph flow through all time points. ICG clearance (%) was quantified. Values shown are mean ± SEM. *p < 0.05 versus control + AAV-GFP, #p < 0.05 versus periodontitis + AAV-VEGFC, at the same time point. (C) Representative 3D scanned sections (upper panels) and reconstructed sections (lower panels) along the longitudinal direction of the maxillae. Bone mineral density (BMD, g/cm2) was analyzed. (D) Representative images of H&E-stained paraffin sections. Measurement of the bone levels by comparing the distance from the cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) in μm was determined. (E) Representative images of TRAP-stained paraffin sections. The percentage of alveolar bone surface covered by osteoclasts (Oc.S/B.S) was determined. (F) Representative images of ALP-stained paraffin sections. The percentage of alveolar bone surface covered by osteoblasts (Ob.S/B.S) was determined. *p < 0.05 in the indicated groups. N = 6. One-way ANOVA followed by Dunnett’s post hoc multiple comparisons test was performed.

    Article Snippet: A recombinant adeno-associated virus (AAV) encoding a full-length human VEGFC cDNA (NM_005429) was purchased from Genechem Biotech Inc (Shanghai, PR China).

    Techniques: Injection, Virus, In Vivo, Staining